Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.

Explorateur d’archives

Parcourir et rechercher des captures

Note importante

Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.

Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.

Parcourir les sites archivés

Parcourir toutes les sources →

Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID-19 vaccines in Canada - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 37: Summary of NACI statement of April 12, 2022: Updated guidance on a first booster dose of COVID-19 vaccines in Canada - Canada.ca We have archived this page and will not be updating it. You can use it for research or…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-first-booster-dose-covid-19-vaccines/summary-april-12-2022.html

Archived 42: Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 42: Summary of NACI statement of July 14, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age - Canada.ca We have archived this page and will not be updating it. You…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-months-5-years/summary-july-14-2022.html

Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age [2022-07-14] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 42: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age [2022-07-14] - Canada.ca We have archived this page and will not be updating it. You can use it for research or…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-moderna-spikevax-covid-19-vaccine-children-6-months-5-years.html

Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 39: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines [2022-09-01] - Canada.ca We have archived this page and will not be updating it. You can use it for research or reference. Language…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-bivalent-omicron-containing-mrna-covid-19-vaccines.html

Archived 43: Summary: First booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age recommendations: NACI statement August 19, 2022 - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 43: Summary: First booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age recommendations: NACI statement August 19, 2022 - Canada.ca We have archived this page and will not be updating…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-first-booster-dose-pfizer-biontech-comirnaty-covid-19-vaccine-children-5-11-years/summary-august-19-2022.html

Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 41: Summary of NACI statement of June 29, 2022: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada - Canada.ca We have archived this page and will not be updating it. You…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-planning-fall-2022-covid-19-vaccine-booster/summary-june-29-2022.html

Archived 41: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada [2022-06-29] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 41: Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada [2022-06-29] - Canada.ca We have archived this page and will not be updating it. You can use it for research or…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-planning-fall-2022-covid-19-vaccine-booster.html

Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age - Canada.ca We have archived this page and will not…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-pfizer-biontech-comirnaty-3-mcg-covid-19-vaccine-children-6-months-4-years/summary-october-21-2022.html

Archived 46: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age [2022-10-21] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 46: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age [2022-10-21] - Canada.ca We have archived this page and will not be updating it. You can use it for…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-pfizer-biontech-comirnaty-3-mcg-covid-19-vaccine-children-6-months-4-years.html

Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age [2022-08-19] - Canada.ca

Health CanadaCaptures 3Dernière capture 18 avr. 2025en
VoirDétailsToutes les captures

Archived 43: Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age [2022-08-19] - Canada.ca We have archived this page and will not be updating it. You can…

URL d’originewww.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-first-booster-dose-pfizer-biontech-comirnaty-covid-19-vaccine-children-5-11-years.html
Page 6314 sur 6399Affichage de 63131 à 63140 sur 63986
« Première← Préc.Suiv. →Dernière »

Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.